CAMBRIDGE, Mass., Sept. 21, 2018 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell
therapies for the sports medicine and severe burn care markets, will be presenting at the following investor and industry
conferences:
- Nick Colangelo, president and CEO, will present at the Ladenburg 2018 Healthcare Conference in New York, NY on Tuesday,
October 2, 2018 at 11:30 AM EDT
http://wsw.com/webcast/ladenburg4/vcel/
- Nick Colangelo, president and CEO, will present at the Cantor Global Healthcare Conference in New York, NY on Wednesday,
October 3, 2018 at 1:40 PM EDT
http://wsw.com/webcast/cantor7/vcel/
- Dan Orlando, Chief Operating Officer, will present at the Cell & Gene Meeting on the Mesa in La Jolla, CA on, Thursday,
October 4, 2018 at 5:15 PM PDT
http://www.meetingonthemesa.com/webcast
About Vericel Corporation
Vericel is a leader in advanced cell therapies for the sports medicine and severe burn care markets. The company markets two cell
therapy products in the United States. MACI® (autologous cultured chondrocytes on porcine collagen membrane) is an
autologous cellularized scaffold product indicated for the repair of symptomatic, single or multiple full-thickness cartilage
defects of the knee with or without bone involvement in adults. Epicel® (cultured epidermal autografts) is a permanent
skin replacement for the treatment of patients with deep dermal or full thickness burns greater than or equal to 30% of total body
surface area. For more information, please visit the company's website at www.vcel.com.
Epicel® and MACI® are registered trademarks of Vericel Corporation. © 2018 Vericel Corporation. All rights
reserved.
Global Media Contacts:
David Schull
Russo Partners LLC
+1 212-845-4271 (office)
+1 858-717-2310 (mobile)
David.schull@russopartnersllc.com
Karen Chase
Russo Partners LLC
+1 646-942-5627 (office)
+1 917-547-0434 (mobile)
Karen.chase@russopartnersllc.com
Investor Contacts:
Chad Rubin
Solebury Trout
crubin@troutgroup.com
+1 (646) 378-2947
Lee Stern
Solebury Trout
lstern@troutgroup.com
+1 (646) 378-2922
